Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma |
Asthma | Phase3 | Greece Spain South Africa Italy Colombia Romania Argentina Hungary Austria Mexico Guatemala Portugal Czechia View All |
A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. |
Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme | Phase1 | United States Switzerland Spain Netherlands Israel View All |
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study |
Sickle Cell Disease | Phase4 | United States Turkey Spain Lebanon Belgium Colombia Germany Oman Italy France Brazil View All |
CAR-T Long Term Follow Up (LTFU) Study |
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program | Phase3 | United States Germany Australia Denmark Belgium Canada Finland France Israel Austria View All |
A 24-week rPMS Study in Real-world Setting for Enerzair |
Asthma | Korea, Republic of | |
Asciminib RMP Study |
Chronic Myeloid Leukemia | Korea, Republic of | |
Asciminib Roll-over Study |
Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Phase4 | United States Spain Germany France Czechia Argentina Denmark Portugal Italy Mexico Canada Brazil Russian Federation Romania Bulgaria Poland Austria View All |
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study |
Relapsing Multiple Sclerosis | Portugal | |
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis |
Multiple Sclerosis | Phase3 | Germany France United States |
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN |
IC-MPGN | Phase3 | United States Spain Italy Brazil Germany Argentina Japan Israel France Canada India Poland Czechia View All |